Funding Will Accelerate Development of a Nanofluidic Antiretroviral Implant Designed to Deliver Continuous HIV Protection for ...

- Celltrion, Inc. (KRX:068270) has announced its participation in the United European Gastroenterology (UEG) Week 2026 to be ...

NueCell Bio, a translational development partner that helps advance cell therapies from scientific discovery to GMP readiness ...

Takeda’s First-in-Class Narcolepsy Drug ORZEYFUL Enters Japan and China Markets Following Regulatory Approvals ...

Danaher Corporation announced a collaboration with NVIDIA to advance autonomous science and help accelerate the pace of ...

Rona Therapeutics announced it has granted Roche an exclusive worldwide license for Rona's investigational RNAi candidate ...

BioAgilytix company, announced the opening of a new Australian laboratory in Sydney, expanding its national footprint to four ...

CellCarta Partners with Waters Corporation to Advance Companion Diagnostics and Next-Generation Flow Cytometry ...

South Korea’s GCCL and LabConnect Partner to Strengthen Global Clinical Trial Operations Across APAC and North America ...

Shanghai Ark Biopharmaceutical Secures US FDA IND Clearance for Phase II Trial of Long-Acting Influenza Prevention Drug ...

In preclinical studies, ISM9546 exhibited sub-nanomolar VAV1 degradation potency across multiple cell-based assays. Oral ...

Exclusive agreement grants Visara worldwide rights outside Greater China to develop HT006.2.2 for neurotrophic keratitis, ...